METAP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.41479999999461E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.761200E-04 |
Normal-vs-Stage2 |
2.12059999999958E-05 |
Normal-vs-Stage3 |
9.47900000047852E-07 |
Normal-vs-Stage4 |
7.3956000001818E-07 |
Stage1-vs-Stage2 |
1.380400E-02 |
Stage1-vs-Stage3 |
4.04720000000136E-05 |
Stage1-vs-Stage4 |
8.46520000000739E-05 |
Stage2-vs-Stage3 |
5.888600E-01 |
Stage2-vs-Stage4 |
4.643200E-01 |
Stage3-vs-Stage4 |
7.874600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.00879999999937E-05 |
Normal-vs-AfricanAmerican |
1.4766000000499E-06 |
Normal-vs-Asian |
2.303600E-02 |
Caucasian-vs-AfricanAmerican |
5.774100E-02 |
Caucasian-vs-Asian |
7.669600E-01 |
AfricanAmerican-vs-Asian |
2.820600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.29489999999943E-05 |
Normal-vs-Female |
5.77290000000064E-05 |
Male-vs-Female |
6.672600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.442300E-03 |
Normal-vs-Age(41-60Yrs) |
5.56139999999816E-05 |
Normal-vs-Age(61-80Yrs) |
3.71399999999911E-05 |
Normal-vs-Age(81-100Yrs) |
2.19469999999111E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.062400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.643400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.944980E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.115800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.910200E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.770200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.356200E-02 |
Normal-vs-Grade 2 |
1.441420E-03 |
Normal-vs-Grade 3 |
1.31100000000384E-06 |
Normal-vs-Grade 4 |
1.33599999951883E-07 |
Grade 1-vs-Grade 2 |
6.053600E-01 |
Grade 1-vs-Grade 3 |
1.777960E-02 |
Grade 1-vs-Grade 4 |
6.838400E-03 |
Grade 2-vs-Grade 3 |
9.94840000045905E-07 |
Grade 2-vs-Grade 4 |
6.40789999950542E-07 |
Grade 3-vs-Grade 4 |
7.731800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.384400E-03 |
Normal-vs-ccB subtype |
1.04749999996212E-06 |
ccA subtype-vs-ccB subtype |
8.13639999819316E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.39169999999289E-05 |
Normal-vs-N1 |
8.02840000000415E-05 |
N0-vs-N1 |
1.290170E-01 |
|
|